Cyfuse Biomedical K.K. (4892.T)

JPY 463.0

(2.89%)

Gross Profit Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual gross profit in 2023 was 37.74 Million JPY , down -84.37% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly gross profit in 2024 Q2 was -7.94 Million JPY , down -227.81% from previous quarter.
  • Cyfuse Biomedical K.K. reported a annual gross profit of 241.49 Million JPY in annual gross profit 2022, down -57.68% from previous year.
  • Cyfuse Biomedical K.K. reported a annual gross profit of 570.6 Million JPY in annual gross profit 2021, up 751.38% from previous year.
  • Cyfuse Biomedical K.K. reported a quarterly gross profit of 6.21 Million JPY for 2024 Q1, down -75.78% from previous quarter.
  • Cyfuse Biomedical K.K. reported a quarterly gross profit of 25.66 Million JPY for 2023 Q4, up 928.78% from previous quarter.

Annual Gross Profit Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Gross Profit of Cyfuse Biomedical K.K. (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 37.74 Million JPY -84.37%
2022 241.49 Million JPY -57.68%
2021 570.6 Million JPY 751.38%
2020 67.02 Million JPY 0.0%

Peer Gross Profit Comparison of Cyfuse Biomedical K.K.

Name Gross Profit Gross Profit Difference
Pharma Foods International Co., Ltd. 48.75 Billion JPY 99.923%
Takeda Pharmaceutical Company Limited 2184.96 Billion JPY 99.998%
Sumitomo Pharma Co., Ltd. 187.98 Billion JPY 99.98%
Shionogi & Co., Ltd. 369.08 Billion JPY 99.99%
Wakamoto Pharmaceutical Co.,Ltd. 3.54 Billion JPY 98.934%
Nippon Shinyaku Co., Ltd. 97.01 Billion JPY 99.961%
Kaken Pharmaceutical Co., Ltd. 38.22 Billion JPY 99.901%
Eisai Co., Ltd. 586.41 Billion JPY 99.994%
Morishita Jintan Co., Ltd. 5.99 Billion JPY 99.371%
Hisamitsu Pharmaceutical Co., Inc. 78.97 Billion JPY 99.952%
Mochida Pharmaceutical Co., Ltd. 52.07 Billion JPY 99.928%
Fuso Pharmaceutical Industries,Ltd. 13.51 Billion JPY 99.721%
Nippon Chemiphar Co., Ltd. 7.73 Billion JPY 99.512%
Tsumura & Co. 68.81 Billion JPY 99.945%
Kissei Pharmaceutical Co., Ltd. 37.34 Billion JPY 99.899%
Torii Pharmaceutical Co., Ltd. 24.79 Billion JPY 99.848%
Towa Pharmaceutical Co., Ltd. 81.38 Billion JPY 99.954%
Fuji Pharma Co., Ltd. 16.51 Billion JPY 99.771%
Zeria Pharmaceutical Co., Ltd. 50.18 Billion JPY 99.925%
KYORIN Holdings, Inc. 51.4 Billion JPY 99.927%
Taiko Pharmaceutical Co.,Ltd. 1.07 Billion JPY 96.502%
Daito Pharmaceutical Co.,Ltd. 9.83 Billion JPY 99.616%
SymBio Pharmaceuticals Limited 4.41 Billion JPY 99.144%
MedRx Co., Ltd 26 Million JPY -45.169%
Mizuho Medy Co.,Ltd. 8.02 Billion JPY 99.53%
Solasia Pharma K.K. 337 Million JPY 88.8%
Modalis Therapeutics Corporation -731 Thousand JPY 5263.338%
ASKA Pharmaceutical Holdings Co.,Ltd. 30.66 Billion JPY 99.877%
Sawai Group Holdings Co., Ltd. 54.31 Billion JPY 99.931%
Toho Holdings Co., Ltd. 112.98 Billion JPY 99.967%
Koa Shoji Holdings Co.,Ltd. 6.63 Billion JPY 99.432%